Bedoukian   RussellIPM   RussellIPM   Piezoelectric Micro-Sprayer


Home
Animal Taxa
Plant Taxa
Semiochemicals
Floral Compounds
Semiochemical Detail
Semiochemicals & Taxa
Synthesis
Control
Invasive spp.
References

Abstract

Guide

Alphascents
Pherobio
InsectScience
E-Econex
Counterpart-Semiochemicals
Print
Email to a Friend
Kindly Donate for The Pherobase

« Previous AbstractFunctional analysis of the guanylyl cyclase type D signaling system in the olfactory epithelium    Next AbstractDevelopment of a Novel Flavored Goat Cheese with Gentiana lutea Rhizomes »

Curr Gastroenterol Rep


Title:Novel Screening Tests for Barrett's Esophagus
Author(s):Codipilly DC; Iyer PG;
Address:"Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA. Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA. iyer.prasad@mayo.edu. Barrett's Esophagus Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA. iyer.prasad@mayo.edu"
Journal Title:Curr Gastroenterol Rep
Year:2019
Volume:20190725
Issue:9
Page Number:42 -
DOI: 10.1007/s11894-019-0710-9
ISSN/ISBN:1534-312X (Electronic) 1522-8037 (Linking)
Abstract:"PURPOSE OF REVIEW: There has been an exponential increase in the incidence of esophageal adenocarcinoma (EAC) over the last half century. Barrett's esophagus (BE) is the only known precursor lesion of EAC. Screening for BE in high-risk populations has been advocated with the aim of identifying BE, followed by endoscopic surveillance to detect dysplasia and early stage cancer, with the intent that treatment can improve outcomes. We aimed to review BE screening methodologies currently recommended and in development. RECENT FINDINGS: Unsedated transnasal endoscopy allows for visualization of the distal esophagus, with potential for biopsy acquisition, and can be done in the office setting. Non-endoscopic screening methods being developed couple the use of swallowable esophageal cell sampling devices with BE specific biomarkers, as well as trefoil factor 3, methylated DNA markers, and microRNAs. This approach has promising accuracy. Circulating and exhaled volatile organic compounds and the foregut microbiome are also being explored as means of detecting EAC and BE in a non-invasive manner. Non-invasive diagnostic techniques have shown promise in the detection of BE and may be effective methods of screening high-risk patients"
Keywords:"Adenocarcinoma/chemistry/*diagnosis/etiology/microbiology Barrett Esophagus/complications/*diagnosis/genetics/microbiology Biomarkers, Tumor/analysis Capsule Endoscopy Early Detection of Cancer/*methods Esophageal Neoplasms/chemistry/*diagnosis/etiology/m;"
Notes:"MedlineCodipilly, Don C Iyer, Prasad G eng Review 2019/07/28 Curr Gastroenterol Rep. 2019 Jul 25; 21(9):42. doi: 10.1007/s11894-019-0710-9"

 
Back to top
 
Citation: El-Sayed AM 2024. The Pherobase: Database of Pheromones and Semiochemicals. <http://www.pherobase.com>.
© 2003-2024 The Pherobase - Extensive Database of Pheromones and Semiochemicals. Ashraf M. El-Sayed.
Page created on 27-12-2024